Skip to main content
logo
Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.320
-0.070 (-2.06%)
Apr 9, 2026, 2:43 PM EDT - Market open

Recursion Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1,7542,1602,6822,3101,4732,917
Market Cap Growth
-35.80%-19.46%16.13%56.84%-49.51%-
Enterprise Value
1,0881,4822,1831,963967.932,401
Last Close Price
3.324.096.769.867.7117.13
PE Ratio
--2.84-4.00-6.24-5.67-11.50
PS Ratio
23.4828.9345.5951.8236.96286.58
PB Ratio
1.581.912.594.983.035.37
P/TBV Ratio
1.321.621.794.422.793.96
P/FCF Ratio
--5.71-7.19-7.71-12.21-14.70
P/OCF Ratio
--5.81-7.47-8.03-17.63-18.39
EV/Sales Ratio
14.5719.8537.1044.0424.29235.89
EV/EBITDA Ratio
--2.63-4.93-6.03-4.14-13.77
EV/EBIT Ratio
--2.29-4.56-5.61-3.94-13.14
EV/FCF Ratio
--3.92-5.85-6.55-8.03-12.10
Debt / Equity Ratio
0.060.060.090.100.090.00
Debt / EBITDA Ratio
-0.14-0.14-0.24-0.16-0.220.00
Debt / FCF Ratio
-0.21-0.21-0.29-0.17-0.420.00
Net Debt / Equity Ratio
-0.59-0.59-0.47-0.74-1.03-0.95
Net Debt / EBITDA Ratio
1.181.181.101.052.132.96
Net Debt / FCF Ratio
1.761.761.301.144.142.60
Asset Turnover
0.050.050.060.070.060.02
Quick Ratio
5.205.203.434.245.5111.27
Current Ratio
5.505.503.814.705.6811.46
Return on Equity (ROE)
-59.54%-59.54%-61.89%-69.12%-46.56%-47.51%
Return on Assets (ROA)
-44.34%-44.34%-45.46%-51.04%-37.47%-40.22%
Return on Invested Capital (ROIC)
-93.02%-93.02%-99.31%-212.50%-284.87%-437.62%
Return on Capital Employed (ROCE)
-50.10%-50.10%-52.59%-60.27%-42.20%-43.56%
Earnings Yield
-36.77%-35.21%-25.00%-16.02%-17.64%-8.70%
FCF Yield
-21.57%-17.51%-13.90%-12.98%-8.19%-6.80%
Buyback Yield / Dilution
-63.18%-63.18%-31.92%-18.41%-40.04%-475.48%
Total Shareholder Return
-63.18%-63.18%-31.92%-18.41%-40.04%-475.48%
Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q